Bio-Rad Laboratories, Inc. Q2 2025 Earnings Preview
Source: SeekingAlpha
2025-07-30 13:06:00 ET
More on Bio-Rad Laboratories, Inc.
- Bio-Rad: With Low Debt And A Stock Price Drop, Is The Company Undervalued?
- Bio-Rad Laboratories, Inc. (BIO) Q1 2025 Earnings Call Transcript
- Life sciences tools companies higher as NIH pauses cancellation of research grants
- Bio-rad outlines updated 2025 guidance amid academic and macro challenges
- Seeking Alpha’s Quant Rating on Bio-Rad Laboratories, Inc.
Read the full article on Seeking Alpha
For further details see:
Bio-Rad Laboratories, Inc. Q2 2025 Earnings Preview
Bio-Rad Laboratories Inc. Class A
NASDAQ: BIO
BIO Trading
11.5% G/L:
$277.42 Last:
471,754 Volume:
$274.72 Open:
BIO Latest News
BIO Stock Data
$8,088,674,023
21,121,296
0.01%
179
N/A
Biotechnology & Life Sciences
Healthcare
US
Hercules
